Pfizer CEO Albert Bourla Describes Vaccine Skeptics as ‘Criminals’

Pfizer CEO Albert Bourla described people who question his company’s experimental vaccine as “criminals” during an interview earlier this week. The Pfizer CEO recently lobbied the FDA to approve a fifth shot in the fall, which is expected to be approved.

An interviewer first drew attention to the “challenges” being faced by big tech companies in combatting “vaccine information” during a sit-down with Bourla. “Correct me if I’m wrong, but I believe I’ve heard you talk about those who would deliberately peddle misinformation as ‘criminals.’ Is that something that you stand by?” Bourla was asked.

“Yes, I do,” replied the Pfizer CEO. “Because they are literally [costing] lives. They know what they are saying is a lie, but they do it despite that.” Bourla then referenced a vaccine injury story and characterized all vaccine injuries as “lies.”

“They did it why? Because they wanted to convince people on the fence, to do the vaccine or not, ‘don’t do it, look his wife died’”, the Pfizer CEO continued. “But forget that, that’s nothing compared to how many people didn’t do the vaccine and died because of that. So they are criminals.”

The Pfizer CEO made similar comments last May when speaking with the WEF-affiliated Atlantic Council. “Those people are criminals,” Bourla told Atlantic Council CEO Frederick Kempe, who joined Klaus Schawb on a panel titled “Are We Ready for A New World Order?” just last week. “They’re not bad people. They’re criminals because they have literally cost millions of lives.”

The German pharmaceutical giant raked in $36 billion in revenue last year, including $12 million in the fourth quarter of 2021. Demand for the vaccine is expected to remain high throughout 2022 as governments are expected to roll out second, and eventually third, booster shots. The FDA recently green lit a second booster for all adults aged 50 and up while the shot is expected to be offered to all adults in the coming weeks. It is likely that a third booster, which would be the fifth shot for recipients, will be approved in the fall.

RELATED: Pfizer Earnings Report Describes Possibility of Unfavorable Safety Data For Vaccine, Risk of ‘Serious’ Adverse Reactions



Cullen McCue